Matteo Panizzi

Dr. Matteo Panizzi

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
EBElena Giovanna Bignami
Elena Giovanna Bignami
MBMichele Berdini
Michele Berdini
MPMatteo Panizzi
Matteo Panizzi
TDTania Domenichetti
Tania Domenichetti
FBFrancesca Bezzi
Francesca Bezzi
VBValentina Bellini
Valentina Bellini
Sepsis is one of the leading causes of mortality in hospital settings, and early diagnosis is a crucial challenge to improve clinical outcomes. Artificial intelligence (AI) is emerging as a valuable resource to address this challenge, with numerous investigations exploring its application to predict and diagnose sepsis early, as well as personalizing its treatment. Machine learning (ML) models are able to use clinical data collected from hospital Electronic Health Records or continuous monitoring to predict patients at risk of sepsis hours before the onset of symptoms. Background/Objectives: Over the past few decades, ML and other AI tools have been explored extensively in sepsis, with models developed for the early detection, diagnosis, prognosis, and even real-time management of treatment strategies. Methods: This review was conducted according to the SPIDER (Sample, Phenomenon of Interest, Design, Evaluation, Research Type) framework to define the study methodology. A critical overview of each paper was conducted by three different reviewers, selecting those that provided original and comprehensive data relevant to the specific topic of the review and contributed significantly to the conceptual or practical framework discussed, without dwelling on technical aspects of the models used. Results: A total of 194 articles were found; 28 were selected. Articles were categorized and analyzed based on their focus—early prediction, diagnosis, mortality or improvement in the treatment of sepsis. The scientific literature presents mixed outcomes; while some studies demonstrate improvements in mortality rates and clinical management, others highlight challenges, such as a high incidence of false positives and the lack of external validation. This review is designed for clinicians and healthcare professionals, and aims to provide an overview of the application of AI in sepsis management, reviewing the main studies and methodologies used to assess its effectiveness, limitations, and future potential.

8 October 2024 in Journal of Clinical Monitoring and Computing
Verified
Journal Article
Open access
PDF file
EBElena Giovanna Bignami
Elena Giovanna Bignami
MPMatteo Panizzi
Matteo Panizzi
FBF. Bezzi
F. Bezzi
MMM. Mion
M. Mion
MBM. Bagnoli
M. Bagnoli
VBV. Bellini
V. Bellini
Postoperative deterioration is often preceded by abnormalities in vital parameters, but limited resources prevent their continuous monitoring in patients with no indication to ICU admission. The development of new technologies allowed the introduction of wearable devices (WDs), enabling the possibility of postoperative monitoring in surgical wards. We performed a Scoping Review to determine the current use of wearable devices as part of Continuous Remote Early Warning Score (CREWS) systems and their efficiency during postoperative period. This Scoping Review was conducted according to PRISMA-ScR guidelines. PICO framework was used before the search to define the review protocol. Systematic literature research has been performed on PubMed, MeSH, MEDLINE and Embase, considering a period between 2018 and February 2024. Prospective and retrospective studies involving patients undergoing cardiac and non-cardiac surgery are included. A total of 10 articles were included in the review. 11 different CE/FDA approved wearable devices were used in the studies analyzed. In all studies the WDs were applied the day of the surgery. The use of WDs as part of CREWS systems is feasible and safe. Furthermore, with the aid of other technologies (LoRa and Artificial Intelligence), they shorten Length of Stay (LOS) and reduce the number of ICU admissions with a reduction in healthcare costs. Continuous monitoring in surgical departments can facilitate the correct and timely identification of postoperative complications. This article is a starting point for the development of new protocols and for the application of these monitoring systems in clinical practice.

20 October 2025 in Sensors
Verified
Journal Article
Open access
PDF file
EBElena Giovanna Bignami
Elena Giovanna Bignami
AFAnna Fornaciari
Anna Fornaciari
SFSara Fedele
Sara Fedele
MMMattia Madeo
Mattia Madeo
MPMatteo Panizzi
Matteo Panizzi
VBValentina Bellini
Valentina Bellini
Wearable devices (WDs) are increasingly integrated into clinical workflows to enable continuous, non-invasive vital signs monitoring. Combined with Artificial Intelligence (AI), these systems can shift clinical monitoring from being reactive to predictive, allowing for earlier detection of deterioration and more personalized interventions. The value of these technologies lies not in absolute measurements, but in detecting physiological parameters trends relative to each patient’s baseline. Such a trend-based approach enables real-time prediction of deterioration, enhancing patient safety and continuity of care. However, despite their shared multiparametric capabilities, WDs are not interchangeable. This narrative review analyzes nine clinically validated devices, Radius VSM® (Masimo Corporation, Irvine, CA, USA), BioButton® (BioIntelliSense Inc., Redwood City, CA, USA. Distributed by Medtronic), Portrait Mobile® (GE HealthCare, Chicago, IL, USA), VitalPatch® (VitalConnect Inc., San Jose, CA, USA), CardioWatch 287-2® (Corsano Health B.V., The Hague, The Netherlands. Distributed by Medtronic), Cosinuss C-Med Alpha® (Cosinuss Gmb, Munich, Germany), SensiumVitals® (Sensium Healthcare Limited, Abingdon, Oxfordshire, UK), Isansys Lifetouch® (Isansys Lifecare Ltd., Abingdon, Oxfordshire, UK), and CheckPoint Cardio® (CheckPoint R&D LTD., Kazanlak, Bulgaria), highlighting how differences in sensor configurations, battery life, connectivity, and validation contexts influence their suitability across various clinical environments. Rather than establishing a hierarchy of technical superiority, this review emphasizes the importance of context-driven selection, considering care setting, patient profile, infrastructure requirements, and interoperability. Each device demonstrates strengths and limitations depending on patient population and operational demands, ranging from perioperative, post-operative, emergency, or post-Intensive Care Unit (ICU) settings. The findings support a tailored approach to WD implementation, where matching device capabilities to clinical needs is key to maximizing utility, safety, and efficiency.

5 June 2024 in Journal of Anesthesia, Analgesia and Critical Care
Verified
Journal Article
Open access
PDF file
EBElena Giovanna Bignami
Elena Giovanna Bignami
MBMichele Berdini
Michele Berdini
MPMatteo Panizzi
Matteo Panizzi
VBValentina Bellini
Valentina Bellini

3 January 2025 in Acta Anaesthesiologica Scandinavica
Verified
Journal Article
Closed access
EBElena Giovanna Bignami
Elena Giovanna Bignami
MPMatteo Panizzi
Matteo Panizzi
VBV. Bellini
V. Bellini

Verified
Journal Article
Open access
PDF file
VBValentina Bellini
Valentina Bellini
MPMatteo Panizzi
Matteo Panizzi
SDStefano Delrio
Stefano Delrio
MBMichele Berdini
Michele Berdini
VRVictor Sapountzakis Ribeiro
Victor Sapountzakis Ribeiro
EBElena Giovanna Bignami
Elena Giovanna Bignami
Background: Chatbots are becoming increasingly valuable in clinical settings, offering rapid access to medical information, aiding documentation, and improving perioperative patient education. Their adaptability makes them promising tools for personalized perioperative risk stratification (PRS) and anesthesia planning, but their definitive role remains uncertain. We aimed to evaluate chatbot performance in PRS compared to standard clinical judgment and to assess the certainty of the evidence supporting their use. Methods: This systematic review (PROSPERO ID: CRD42025642357) followed PRISMA extended and PRISMA-S guidelines. The population was defined according to the PICO framework: we included adult surgical patients undergoing anesthesia assessment (P), evaluated with LLM-based chatbots for perioperative risk stratification and anesthesia planning (I), compared with traditional clinician assessment (C), and extracted performance metrics (O). Comprehensive searches of PubMed, MEDLINE, Scopus, Embase, Google Scholar, Open Gray, ClinicalTrials.gov, WHO ICTRP, and Cochrane Library Central were conducted through January 2026. Risk of bias and study quality were assessed using PROBAST-AI, RoB-2, and ROBINS-I. Certainty of the evidence was assessed using GRADE system. A random-effects meta-analysis of pooled chatbot accuracy was performed, with subgroup analyses by ASA status and perioperative risk stratification. A sensitivity analysis was performed with a leave-one-out exclusion test. Results: Eleven studies published between 2023 and January 2026 were included (N = 227,059 patients). Five prospective cohorts, two large retrospective cohorts, one randomized non-inferiority trial, and three non-clinical or mixed-methods studies were found. Meta-analysis showed that the pooled accuracy of LLM-based chatbots for AI–clinician concordance in perioperative risk stratification and ASA classification was 0.90 [95% CI: 0.42–0.99; 95% prediction interval 0.03–1.00]. Subgroup analyses indicated that the ASA status prediction subgroup reached a pooled accuracy of 0.91 (95% CI: 0.46 to 0.99), whereas the exploratory perioperative risk stratification subgroup showed an accuracy of 0.73 (95% CI: 0.10 to 0.98). Performance decreased with increasing patient complexity. Evidence is limited by small sample sizes, extreme sample size skew toward a single center, geographic bias, inconsistent outcome definitions and performance metrics, and incomplete reporting of adverse events. Most studies lacked prospective trial registration or robust control for confounding, and publication bias cannot be excluded. Conclusions: LLM-based chatbots show promising performance in routine perioperative risk stratification but remain unreliable in complex cases, with potential safety concerns. Given the overall very low GRADE certainty of evidence, these tools should be used as clinician-supervised decision support aids for routine ASA assessment, and should not be relied upon for autonomous use in complex cases or for general perioperative risk stratification. Other: This research received no external funding. PROSPERO ID: CRD42025642357.